NDC 62207-814 – Naproxen Sodium and Diphenhydramine HCl
Naproxen Sodium 220 mg/1; Diphenhydramine Hydrochloride 25 mg/1 · Tablet, Film Coated · Oral
Product NDC62207-814
Product details
- Brand name
- Naproxen Sodium and Diphenhydramine HCl
- Generic name
- Naproxen Sodium and Diphenhydramine HCl
- Labeler
- Granules India Ltd
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- ANDA · ANDA213663
- Marketed since
- February 20, 2021
- Listing expires
- December 31, 2026
- Pharmacologic class
- Histamine-1 Receptor Antagonist; Nonsteroidal Anti-inflammatory Drug
Active ingredients
- Naproxen Sodium 220 mg/1
- Diphenhydramine Hydrochloride 25 mg/1
Uses, dosage, side effects and warnings for Naproxen Sodium and Diphenhydramine HCl →
Package NDC codes (4)
| Package NDC | Description | Since |
|---|---|---|
| 62207-814-38 | 37500 TABLET, FILM COATED in 1 POUCH (62207-814-38) | Feb 20, 2021 |
| 62207-814-39 | 7500 TABLET, FILM COATED in 1 POUCH (62207-814-39) | Feb 20, 2021 |
| 62207-814-47 | 500 TABLET, FILM COATED in 1 BOTTLE (62207-814-47) | Feb 20, 2021 |
| 62207-814-95 | 1 BOTTLE in 1 CARTON (62207-814-95) / 20 TABLET, FILM COATED in 1 BOTTLE | Feb 20, 2021 |
Other Naproxen Sodium and Diphenhydramine HCl products
- 69238-1422 Naproxen Sodium 220 mg/1; Diphenhydramine Hydrochloride 25 mg/1 · Tablet, Film Coated · Amneal Pharmaceuticals NY LLC
- 11673-819 Diphenhydramine Hydrochloride 25 mg/1; Naproxen Sodium 220 mg/1 · Tablet · TARGET CORPORATION